Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells

Ítems similars

• Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells
  per: Lai, I-Lu, et al.
  Publicat: (2014)
• Retraction: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent
  per: Chu, Po-Chen, et al.
  Publicat: (2019)
• Retraction: Corrigendum: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent
  per: Chu, Po-Chen, et al.
  Publicat: (2019)
• Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42()()
  per: Henderson, Sally E., et al.
  Publicat: (2016)
• Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer
  per: Chu, Po-Chen, et al.
  Publicat: (2016)